elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q22241831-4586AFC0-C9A3-4297-933E-E4755E5D46FC
Q22241831-4586AFC0-C9A3-4297-933E-E4755E5D46FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22241831-4586AFC0-C9A3-4297-933E-E4755E5D46FC
Refractory schizophrenia and atypical antipsychotics
P2860
Q22241831-4586AFC0-C9A3-4297-933E-E4755E5D46FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22241831-4586AFC0-C9A3-4297-933E-E4755E5D46FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d3ede43abf3a2fbde9f1cd8d1ab7e59ed4c04b1
P2860
The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study.